Black Diamond Therapeutics, Inc.
BDTXNASDAQHealthcare● Active
$1.85
$-0.12(-6.09%)
Market Cap$106008282
P/E Ratio—
52W High$4.94
52W Low$1.85
Black Diamond Therapeutics, Inc.（BDTX）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · BDTX · 截至 2026-06-08
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $70.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Cost of Revenue | $0.33M | $0.00M | $0.44M | $0.00M | $0.00M |
| Gross Profit | $69.67M | $0.00M | ($0.44M) | $0.00M | $0.00M |
| Gross Margin %(computed) | 99.54% | — | — | — | — |
| Operating Expenses | |||||
| R&D Expenses | $33.56M | $51.31M | $58.91M | $64.44M | $96.83M |
| G&A Expenses | $16.57M | $27.47M | $27.11M | $28.39M | $30.04M |
| Total Operating Expenses | $49.80M | $78.78M | $86.02M | $92.83M | $126.87M |
| Operating Income | $19.87M | ($78.78M) | ($86.46M) | ($92.83M) | ($126.87M) |
| Operating Margin %(computed) | 28.39% | — | — | — | — |
| Interest Income | $4.06M | $2.18M | $1.92M | $2.03M | $3.46M |
| Interest Expense | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Income Before Tax | $22.37M | ($69.68M) | ($82.44M) | ($91.17M) | ($125.60M) |
| Income Tax Expense | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Net Income | $22.37M | ($69.68M) | ($82.44M) | ($91.17M) | ($125.60M) |
| Net Margin %(computed) | 31.95% | — | — | — | — |
| Per Share & EBITDA | |||||
| EPS (Basic) | $0.39 | $-1.27 | $-1.88 | $-2.52 | $-3.47 |
| Wtd Avg Shares | 56.87M | 55.03M | 43.95M | 36.23M | 36.19M |
| EBITDA | $20.20M | ($78.44M) | ($86.02M) | ($92.32M) | ($126.67M) |
| EBITDA Margin %(computed) | 28.85% | — | — | — | — |
数据来源：Financial Modeling Prep · 最后更新：2026-06-08 · USD · M
深入了解Black Diamond Therapeutics, Inc.
关于Black Diamond Therapeutics, Inc.（BDTX）损益表
Black Diamond Therapeutics, Inc.（BDTX）损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年，BDTX实现营收$0.07B，毛利润$0.07B（毛利率99.54%），净利润$0.02B（净利率31.95%）。
常见问题
BDTX · 4 问Black Diamond Therapeutics, Inc.（BDTX）2025财年营收为$0.07B，同比up—%。
BDTX revenueBDTX salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08